The pro-oncogenic function of SOX4 in breast cancer is widely attributed to its ability to modulate epithelial-to-mesenchymal transition (EMT), activation of multiple pro-proliferative or pro-survival signaling pathways, increased angiogenesis as well as its role in regulating cancer cell stemness16–20. This evidence concerns the gene SOX4 and breast cancer.